Incidence, Pathogenesis, and Management of Sepsis An Overview

被引：20

作者：

Kleinpell, Ruth M. ^{[1
,2
]}

Graves, Brian T. ^{[3
]}

Ackerman, Michael H. ^{[4
]}

机构：

[1] Rush Univ, Coll Nursing, Chicago, IL 60612 USA

[2] Our Lady Resurrect Med Ctr, Chicago, IL 60612 USA

[3] Univ Rochester, Sch Nursing, Acute Care Nurse Practitioner Program, Rochester, NY USA

[4] Univ Rochester, Med Ctr, Strong Mem Hosp, Rochester, NY 14642 USA

来源：

AACN ADVANCED CRITICAL CARE | 2006年 / 17卷 / 04期

关键词：

sepsis; sepsis management; sepsis pathogenesis;

D O I：

10.1097/01256961-200610000-00005

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

Sepsis is a complex condition that occurs as a result of the systemic manifestation of infection. It is associated with high morbidity and mortality risks for critically ill patients. Assessment and monitoring aimed at early recognition and treatment, on the basis of evidence-based guidelines, are advocated for optimizing outcomes for patients with severe sepsis. Awareness of the risk factors, clinical signs and symptoms, pathophysiology, and updates in the management of sepsis can enhance the nursing care for patients with severe sepsis to promote best practices for sepsis care in the intensive care unit. This article reviews the incidence and pathophysiology of sepsis, highlighting updates in treatment and implications for nursing care.

引用

页码：385 / 393

页数：9

共 34 条

[1] Vascular bed-specific hemostasis: Role of endothelium in pathogenesis [J].

Aird, WC .

CRITICAL CARE MEDICINE, 2001, 29 (07) :S28-S34

[2] Elevation of troponin I in sepsis and septic shock [J].

Ammann, P ;

Fehr, T ;

Minder, EI ;

Günter, C ;

Bertel, O .

INTENSIVE CARE MEDICINE, 2001, 27 (06) :965-969

[3] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].

Angus, DC ;

Linde-Zwirble, WT ;

Lidicker, J ;

Clermont, G ;

Carcillo, J ;

Pinsky, MR .

CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310

[4] Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock [J].

Balk, RA .

CRITICAL CARE CLINICS, 2000, 16 (02) :337-+

[5]

Bjerke Nancy B, 2004, Crit Care Nurs Q, V27, P295

[6] The immunopathogenesis of sepsis [J].

Cohen, J .

NATURE, 2002, 420 (6917) :885-891

[7] STREPTOCOCCUS-PNEUMONIAE ANCHOR TO ACTIVATED HUMAN-CELLS BY THE RECEPTOR FOR PLATELET-ACTIVATING-FACTOR [J].

CUNDELL, DR ;

GERARD, NP ;

GERARD, C ;

IDANPAANHEIKKILA, I ;

TUOMANEN, EI .

NATURE, 1995, 377 (6548) :435-438

[8] THE CORONARY CIRCULATION IN HUMAN SEPTIC SHOCK [J].

CUNNION, RE ;

SCHAER, GL ;

PARKER, MM ;

NATANSON, C ;

PARRILLO, JE .

CIRCULATION, 1986, 73 (04) :637-644

[9]

Das UN, 2006, ADV SEPSIS, V5, P52

[10] Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock [J].

Dellinger, RP ;

Carlet, JM ;

Masur, H ;

Gerlach, H ;

Calandra, T ;

Cohen, J ;

Gea-Banacloche, J ;

Keh, D ;

Marshall, JC ;

Parker, MM ;

Ramsay, G ;

Zimmerman, JL ;

Vincent, JL ;

Levy, MM .

CRITICAL CARE MEDICINE, 2004, 32 (03) :858-873

← 1 2 3 4 →